Eric Luedke

Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease

Joseph Markowitz, Taylor Brooks, Megan Duggan et al. · Cancer Immunology Immunotherapy · 2014 · 121 citations · Full text

Pancreatic Cancer, Medicine, Immunology +6

Cetuximab therapy in head and neck cancer: Immune modulation with interleukin-12 and other natural killer cell–activating cytokines

Eric Luedke, Alena Cristina Jaime‐Ramirez, Neela Bhave et al. · Surgery · 2012 · 70 citations · Full text

Neck Cancer, Cancer Immunosurveillance, Cetuximab Therapy +13

IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells

Elizabeth L. McMichael, Alena Cristina Jaime‐Ramirez, Kristan Guenterberg et al. · Clinical Cancer Research · 2016 · 69 citations · Full text

A naonoporous cell-therapy device with controllable biodegradation for long-term drug release

Hongyan He, Eric Luedke, Xulang Zhang et al. · Journal of Controlled Release · 2012 · 16 citations · Full text

Cell-based Drug Delivery, Long-term Drug Release, Naonoporous Cell-therapy Device +6

A Phase I Trial of Bortezomib and Interferon-a-2b in Metastatic Melanoma

Joseph Markowitz, Eric Luedke, Valerie P. Grignol et al. · Journal of Immunotherapy · 2013 · 15 citations · Full text